Related Experiment Video

Updated: May 12, 2026

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

Therapeutic strategies targeting glioblastoma stem cells

Estefania Carrasco-Garcia1, Nicolas Sampron, Paula Aldaz

  • 1Neurooncology group, Biodonostia Institute, Paseo Dr. Beguiristain s/n, E-20014 San Sebastian, Spain.

Recent Patents on Anti-Cancer Drug Discovery
|April 24, 2013
PubMed

Insights

Glioblastoma stem cells (GSCs) drive aggressive brain tumor growth and recurrence. Targeting these GSCs offers a promising strategy for developing more effective glioblastoma treatments.

Area of Science:

  • Neuro-oncology
  • Cancer Stem Cell Biology

Background:

  • Glioblastoma is an aggressive, lethal adult brain tumor with poor therapeutic outcomes.
  • Tumor heterogeneity contributes to treatment resistance.
  • Glioblastoma stem cells (GSCs) are implicated in tumor initiation, maintenance, and recurrence.

Purpose of the Study:

  • To review current knowledge on glioblastoma stem cells (GSCs).
  • To highlight the role of GSCs in glioblastoma pathogenesis.
  • To discuss implications for novel therapeutic strategies targeting GSCs.

Main Methods:

  • Literature review of glioblastoma and GSC research.
  • Analysis of current therapeutic challenges.
  • Inclusion of recent relevant patents.

Main Results:

  • GSCs are a critical subpopulation driving glioblastoma.
  • GSC heterogeneity contributes to treatment failure.
  • Understanding GSCs is key to overcoming therapeutic resistance.

Conclusions:

  • Targeting glioblastoma stem cells is essential for improving patient survival.
  • Further characterization of GSCs will facilitate the development of novel therapies.
  • Recent patents indicate active research in GSC-targeted treatments.

More Related Videos

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...